Antidote

APRIL 9, 2024

Understanding how to recruit patients for clinical trials can be one of the most challenging aspects of performing medical research. Sponsors and sites have more tools at their disposal than ever before, but keeping track of how to use these various outreach methods can be time-consuming. Additionally, using a mix of outreach is typically the best strategy to reach the highest number of potentially qualified patients — meaning observing best practices across marketing disciplines is advised.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Marketing 52

BioSpace

APRIL 11, 2024

While women’s clinical trial participation has increased, clinical trials still largely are not designed for women.

Clinical Trials 66

Clinical Trials Clinical Trials Trials 66

Imperical Blog

APRIL 9, 2024

Clinical trials have become more and more complex over the last decade, largely due to the challenges driven by an increasingly global reach. As a sponsor, are you making it hard for clinical trial teams? Learn about a unique solution to managing clinical trial binders.… The post Clinical Trial Binders: Are You Doing it the Hard Way? appeared first on Imperial Clinical Research Services Blog.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

APRIL 11, 2024

It’s 2024 and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another. How did we get here? And how do we get past it? On today’s pharmaphorum podcast, host Jonah Comstock speaks with Iddo Peleg, CEO of Yonalink, about these very questions.

Clinical Trials 59

Clinical Trials Clinical Trials Trials 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Bio Pharma Dive

APRIL 8, 2024

Underrepresentation of women in clinical trials affects the resulting drugs that become available later. Even small changes could boost participation.

Clinical Trials 299

Clinical Trials Clinical Trials Trials Drugs 299

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 7, 2024

A drug used to treat diabetes slowed the progression of motor issues associated with Parkinson’s disease, a study published in the New England Journal of Medicine said Wednesday. Parkinson’s is a devastating nervous system disorder affecting 10 million people worldwide, with no current cure.

Drugs 231

Drugs Medicine Clinical Trials Clinical Trials 231

Outsourcing Pharma

APRIL 8, 2024

Individuals diagnosed with Duchenne muscular dystrophy (DMD) often develop compensatory movement patterns due to muscle weakening.

Development 52

Development Contract Manufacturing Manufacturing 52

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 8, 2024

Turning off a gene early in mouse development led researchers to end up with an accidental six-legged embryonic mammal. This strange result took the spinal cord research of developmental biologists Anastasiia Lozovska and Moisés Mallo and their colleagues at Portugal’s Gulbenkian Science Institute in a new direction.

Scientist 242

Scientist Gene Research Development 242

Bio Pharma Dive

APRIL 8, 2024

Recent biotech company acquisitions have put emerging schizophrenia treatments in focus. But many development hurdles still stand in the way of new medicines for the brain.

Medicine 344

Medicine Drugs Development 344

Pharmaceutical Technology

APRIL 8, 2024

The FDA has approved the NDA for SH-201, an oral liquid drug that slows or stops the growth of certain types of leukaemia.

Drugs 264

Drugs 264

Advertisement

Clinical Supply

Worldwide Clinical Trials

APRIL 8, 2024

By Rolana Avrumson, MS, Vice President of Clinical Projects, Clinical Assessment Technologies In the intricate world of clinical trials, the precision and reliability of clinical assessments stand as pivotal factors in determining a trial’s success. Expertly managed clinical assessments by a team with fastidious attention to detail optimizes precision and reliability and helps you successfully navigate the complex terrain of clinical research.

Clinical Research 189

Clinical Research Trials Clinical Trials Clinical Trials 189

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 9, 2024

In the US, roughly two out of every three people with Alzheimer’s is a woman, a statistic that could be partially explained by the fact women typically live longer than men. Yet researchers have suspected there could be more to the story.

Hormones 246

Hormones Research Clinical Trials Clinical Trials 246

Bio Pharma Dive

APRIL 10, 2024

The first medicine approved for PPD, Sage’s Zulresso, never gained traction. The company is in the midst of launching its second, but long-standing challenges could slow uptake.

Medicine 325

Medicine Drugs 325

Pharmaceutical Technology

APRIL 12, 2024

Moderna has announced the halt of its project to build a messenger ribonucleic acid (mRNA) manufacturing facility in Kenya.

Manufacturing 246

Manufacturing 246

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

Rethinking Clinical Trials

APRIL 10, 2024

Dr. Corita Grudzen, principal investigator of PRIM-ER In this Friday’s PCT Grand Rounds, Corita Grudzen of the Memorial Sloan Kettering Cancer Center will present “Primary Palliative Care for Emergency Medicine, a Cluster Randomized Stepped-Wedge Trial Across 33 Emergency Departments,” including the results of the PRIM-ER trial. The Grand Rounds session will be held on Friday, April 12, 2024, at 1:00 pm eastern.

Trials 182

Trials Clinical Trials Clinical Trials Medicine 182

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 9, 2024

Exports of Ayush (Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa-Rigpa and Homoeopathy) drugs and herbal products from the country have reported 1.65 per cent growth during the first ten months of the current fiscal year. The growth in the month of January stood at 14.

Production 245

Production Drugs Clinical Trials Clinical Trials 245

Bio Pharma Dive

APRIL 10, 2024

The deal, which company CEO Reshma Kewalramani described as “just the right fit,” is the largest acquistion in Vertex’s 35-year history.

317

317

Pharmaceutical Technology

APRIL 8, 2024

J&J and Legend’s CAR-T cell therapy has been approved as a second-line therapy for patients with multiple myeloma (MM).

246

246

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Pharma Times

APRIL 12, 2024

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all cases

Research 158

Research 158

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2024

The Drugs Technical Advisory Board (DTAB) of the Union health ministry has once again recommended prohibiting the manufacture, sale and distribution of pain relief drug combination S(+) etodolac+paracetamol, after considering a sub-committee report.

Manufacturing 244

Manufacturing Sales Drugs Clinical Trials 244

Bio Pharma Dive

APRIL 10, 2024

The company said the pause is necessary to meet regulatory limits on nitrosamine, but added it will not affect commercial supply nor regulatory review of the drug in early breast cancer.

Manufacturing 299

Manufacturing Drugs Trials 299

Pharmaceutical Technology

APRIL 11, 2024

The oral drug, which gained UK approval in September 2023, is used for the prevention of both chronic and episodic migraines.

Drugs 244

Drugs 244

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Pharma Times

APRIL 11, 2024

RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR

Research 151

Research 151

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 10, 2024

Scientists looking to tackle our ongoing obesity crisis have made an important discovery: Intermittent calorie restriction leads to significant changes both in the gut and the brain, which may open up new options for maintaining a healthy weight.

Scientist 239

Scientist Research Clinical Trials Clinical Trials 239

Bio Pharma Dive

APRIL 9, 2024

The company plans to submit the trial data to regulators in a bid to win approval of its vaccine Abrysvo in adults as young as 18 years old.

Regulation 278

Regulation Vaccine Vaccination Trials 278

Pharmaceutical Technology

APRIL 8, 2024

Bristol Myers Squibb (BMS) and 2seventy bio’s Abecma have received FDA approval for relapsed or refractory multiple myeloma (RRMM).

FDA Approval 239

FDA Approval 239

Advertisement

Clinical Supply

Pharma Times

APRIL 8, 2024

The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs

Research 142

Research 142

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2024

Using viruses that infect bacteria to detect proteins sprouted by a notorious parasite, scientists have honed in on possible vaccine targets for schistosomiasis, a neglected tropical disease that currently affects an estimated 600 million people worldwide, causing 280,000 deaths per year.

Vaccine 223

Vaccine Vaccination Bacteria Protein 223

Bio Pharma Dive

APRIL 8, 2024

The results were the second time Novo has shown its weight loss treatment can help with the condition, and may help it secure broader use of the drug.

Trials 245

Trials Drugs 245

Pharmaceutical Technology

APRIL 12, 2024

As the UK tackles several drug shortages, UK charities and pharmacists called for urgent action to be taken.

Drugs 195

Drugs 195

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials